TRN Q1 2026 Earnings EPS Surprises to the Upside Despite Market Skepticism FTAIM Q1 2026 Earnings Preferred Dividend Coverage in Focus After EPS Miss ALGS Q1 2026 Earnings NarrowerThanExpected Loss as Aligos Therapeutics Advances Pipeline BeyondSpring BYSI Q1 2026 Earnings Narrowing Loss and No Revenue as ClinicalStage Biotech Advances Pipeline RDCM Q1 2026 Earnings EPS Slightly Beats Estimates Amid Mixed Market Reaction Hennessy Advisors Q1 2026 Earnings EPS of 024 Reported Bond Price Edges Lower